West Oak Capital, LLC Recursion Pharmaceuticals, Inc. Transaction History
West Oak Capital, LLC
- $2.59 Billion
- Q1 2025
A detailed history of West Oak Capital, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, West Oak Capital, LLC holds 600 shares of RXRX stock, worth $2,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
600Holding current value
$2,856% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
357Shares Held
289MCall Options Held
3.41MPut Options Held
3.53M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$166 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$154 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$116 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$82.4 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$69.8 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $859M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...